Global search

Find data and evidence

Type at least 2 characters. Use arrow keys to review and Enter to open.

Peer reviewedOpen accessPlague

Stability of live plague vaccine production: Analysis of potency using Shewhart charts

Biological Products. Prevention, Diagnosis, Treatment·

I. V. Kasina, I. A. Alekseeva, S. A. Alekseeva, M. V. Abramtseva

DOI
10.30895/2221-996x-2026-753
PMID
PMCID
OpenAlex
W7203603149
Study type
Journal article
Publisher
SCEEMP
Article type
journal-article
Integrity
current

Why this research matters now

The findings indicate that statistical process-control methods were used to evaluate consistency of live plague vaccine potency during production. The supplied evidence does not establish clinical effectiveness, safety outcomes, population protection, or a current public-health threat.

01

Structured evidence summary

Research question

The study evaluated whether potency measurements and Shewhart control charts could be used to assess the stability of live plague vaccine production.

Study design

This was a retrospective analysis of potency quality-control data, using individual-value and moving-range Shewhart charts together with Pearson correlation analysis.

Population and setting

The analysis covered 121 live plague vaccine batches manufactured in the Russian Federation between 2012 and 2025. It used manufacturer summary protocols and results from a Testing Center.

Main findings

For 2012–2018, the control charts showed patterns classified as process instability, including observations or trends beyond control limits. For 2019–2025, after reported manufacturing-process optimization, fewer special-cause signals and longer periods within control limits were observed. Manufacturer and Testing Center potency results had a reported Pearson correlation of 0.7.

Public-health relevance

The findings indicate that statistical process-control methods were used to evaluate consistency of live plague vaccine potency during production. The supplied evidence does not establish clinical effectiveness, safety outcomes, population protection, or a current public-health threat.

Important limitations

The supplied material does not state study limitations. This summary relies on a single supplied article abstract and associated metadata; the original paper is required for decision-grade assessment of the methods, control-chart assumptions, process changes, data completeness, and interpretation of the correlation.

GIDS interpretation

The article is discoverable in a plague and vaccination context and concerns vaccine manufacturing quality control in the Russian Federation. These classifications and article findings do not confirm or characterize a live surveillance signal.

02

Related GIDS surveillance

Literature context does not validate, explain, or change a surveillance signal. Exact and contextual relationships are shown separately.

03

Evidence relationships

This article has 5 auditable classifier relationships to diseases, places, topics, and study design.

about diseaseaddresses topicevaluates interventionstudied population settinguses study design